Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of topical NEOSH101 in men with androgenetic alopecia
2007-000511-28Phase 2Completed
- Sponsor
- Neosil
- Start
- Feb 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of neosh101 in androgenetic alopecia (AGA) (4 arms), sponsored by Neosil. Primary endpoint: Change in hair density. Started Feb 2007; status: completed.
02
Drugs
neosh101
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on 2007-000511-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000511-28.